Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a camera replace wires for monitoring newborns?

NCT ID NCT07799870

Knowledge-focused Sponsor: Xim Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This study tests whether Lifelight software can measure vital signs in newborns by analyzing video of their skin, without any physical contact. Researchers will record short videos of babies in the neonatal intensive care unit while standard monitors track heart rate, breathing, oxygen, blood pressure, and temperature at the same time. The goal is to train the software to recognize vital signs from the video and compare its accuracy to standard care. If successful, this approach could offer a gentler way to monitor the smallest patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lifelight software, a camera-based system that measures vital signs from video of the skin
What this could lead to
If it works, this could lead to a contact-free way to monitor heart rate, breathing, oxygen, and blood pressure in fragile newborns, reducing the need for wires and skin sensors.
What could go wrong
This is an early technical study, not a treatment trial. The software may not reach the accuracy needed for medical use, and video quality or baby movement could limit results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 256 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Neonates and infants (256 participants) in the NICU.

Ages

0 to 12 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants admitted to the NICU (who may subsequently be moved onto a different inpatient ward) Exclusion Criteria: * Infants who are on a palliative care pathway

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neonatal diseases and abnormalities are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neonatal diseases and abnormalities Vital sign monitoring

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Royal London Hospital

    RECRUITING

    London, London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.